We are grateful to Santoro et al. for commenting on our paper [1]. We agree that more work is necessary to compare outcomes in high risk women screened with breast MRI compared to no intensive screening. We also agree that obtaining such a control group is increasingly difficult. We are also in agreement that the current results in terms of tumor size, lymph node status, and survival are nonetheless encouraging. We acknowledge that we had overlooked the HIBCRIT Study final results paper [2] and thank Santoro et al. for bringing this to our attention.
Yours truly,
Prof D Gareth Evans MD FRCP
References
Gareth ED, Nisha K, Yit L et al (2014) MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat 145:663–672
Sardanelli F, Podo F, Santoro F et al (2011) Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 Study) Final results. Invest Radiol 46:94–105
Author information
Authors and Affiliations
Corresponding author
Additional information
This rebuttal letter refers to the letter to the editor article available at 10.1007/s10549-014-3097-1.
Rights and permissions
About this article
Cite this article
Evans, D. Response to Santoro et al. Breast Cancer Res Treat 147, 689 (2014). https://doi.org/10.1007/s10549-014-3101-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-014-3101-9